Loading…

Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke

Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of str...

Full description

Saved in:
Bibliographic Details
Published in:Acta medica Iranica 2011, Vol.49 (3), p.149-152
Main Authors: Roudbary, Seyed Ali, Saadat, Farshid, Forghanparast, Kambiz, Sohrabnejad, Reza
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 152
container_issue 3
container_start_page 149
container_title Acta medica Iranica
container_volume 49
creator Roudbary, Seyed Ali
Saadat, Farshid
Forghanparast, Kambiz
Sohrabnejad, Reza
description Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941</doaj_id><sourcerecordid>872436667</sourcerecordid><originalsourceid>FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3</originalsourceid><addsrcrecordid>eNpdkUtLxTAQhYsoen38BQluXBXybJKlXHxcEFyo6zJJJ5pr22jaCv57g6-FqxkOH4dzZnaqFdNC1baxcrdaUSpl3VCuDqrDadpSKgxner864KwxTFO2qvAe8zKQdZ0R_BzfkbzmNGMcSY_v2BOYCBAX0wD5BTMJKZMuhoAZxznCHNNIUiBx8s84RE9CTgMpa8r5GZ6KMM05veBxtRegn_DkZx5Vj1eXD-ub-vbuerO-uK07zsxcdxQd-sDRBKNUxy0KEEAZsMZqBtwK5ShqAUY7ROkVOt15BcEIT6Vx4qjafPt2Cbbta44l9kebILZfQspPLeQ5-h5bKS04ywxD20juwCmkQgdpPVfeSla8zr-9ykHeFpzmdig1se9hxLRMrdFciqZpdCHP_pHbtOSxFC2QMEpyYwt0-gMtbsDuL9zvK8Qnx8CGZg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>873854289</pqid></control><display><type>article</type><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</creator><creatorcontrib>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</creatorcontrib><description>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P&lt;0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</description><identifier>ISSN: 0044-6025</identifier><identifier>EISSN: 1735-9694</identifier><identifier>PMID: 21681701</identifier><language>eng</language><publisher>Iran: Tehran University of Medical Sciences</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers - blood ; Brain Ischemia - blood ; Brain Ischemia - complications ; Brain Ischemia - diagnosis ; C-Reactive Protein - analysis ; Cerebrovascuar Accidents ; Diagnosis, Differential ; Female ; Hemorrhagic Stroke ; High Sensitive C-reactive Protein (hs-CRP) ; Humans ; Intracranial Hemorrhages - blood ; Intracranial Hemorrhages - complications ; Intracranial Hemorrhages - diagnosis ; Ischemic Stroke ; Male ; Middle Aged ; Stroke - etiology</subject><ispartof>Acta medica Iranica, 2011, Vol.49 (3), p.149-152</ispartof><rights>Copyright Dr Ali Akbari Sari, Director of The Commission for Accreditation &amp; Improvement of Iranian Medical Journals 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/873854289/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/873854289?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,4024,25753,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21681701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roudbary, Seyed Ali</creatorcontrib><creatorcontrib>Saadat, Farshid</creatorcontrib><creatorcontrib>Forghanparast, Kambiz</creatorcontrib><creatorcontrib>Sohrabnejad, Reza</creatorcontrib><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><title>Acta medica Iranica</title><addtitle>Acta Med Iran</addtitle><description>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P&lt;0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - blood</subject><subject>Brain Ischemia - blood</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - diagnosis</subject><subject>C-Reactive Protein - analysis</subject><subject>Cerebrovascuar Accidents</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Hemorrhagic Stroke</subject><subject>High Sensitive C-reactive Protein (hs-CRP)</subject><subject>Humans</subject><subject>Intracranial Hemorrhages - blood</subject><subject>Intracranial Hemorrhages - complications</subject><subject>Intracranial Hemorrhages - diagnosis</subject><subject>Ischemic Stroke</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Stroke - etiology</subject><issn>0044-6025</issn><issn>1735-9694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkUtLxTAQhYsoen38BQluXBXybJKlXHxcEFyo6zJJJ5pr22jaCv57g6-FqxkOH4dzZnaqFdNC1baxcrdaUSpl3VCuDqrDadpSKgxner864KwxTFO2qvAe8zKQdZ0R_BzfkbzmNGMcSY_v2BOYCBAX0wD5BTMJKZMuhoAZxznCHNNIUiBx8s84RE9CTgMpa8r5GZ6KMM05veBxtRegn_DkZx5Vj1eXD-ub-vbuerO-uK07zsxcdxQd-sDRBKNUxy0KEEAZsMZqBtwK5ShqAUY7ROkVOt15BcEIT6Vx4qjafPt2Cbbta44l9kebILZfQspPLeQ5-h5bKS04ywxD20juwCmkQgdpPVfeSla8zr-9ykHeFpzmdig1se9hxLRMrdFciqZpdCHP_pHbtOSxFC2QMEpyYwt0-gMtbsDuL9zvK8Qnx8CGZg</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Roudbary, Seyed Ali</creator><creator>Saadat, Farshid</creator><creator>Forghanparast, Kambiz</creator><creator>Sohrabnejad, Reza</creator><general>Tehran University of Medical Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2011</creationdate><title>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</title><author>Roudbary, Seyed Ali ; Saadat, Farshid ; Forghanparast, Kambiz ; Sohrabnejad, Reza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - blood</topic><topic>Brain Ischemia - blood</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - diagnosis</topic><topic>C-Reactive Protein - analysis</topic><topic>Cerebrovascuar Accidents</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Hemorrhagic Stroke</topic><topic>High Sensitive C-reactive Protein (hs-CRP)</topic><topic>Humans</topic><topic>Intracranial Hemorrhages - blood</topic><topic>Intracranial Hemorrhages - complications</topic><topic>Intracranial Hemorrhages - diagnosis</topic><topic>Ischemic Stroke</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Stroke - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roudbary, Seyed Ali</creatorcontrib><creatorcontrib>Saadat, Farshid</creatorcontrib><creatorcontrib>Forghanparast, Kambiz</creatorcontrib><creatorcontrib>Sohrabnejad, Reza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Acta medica Iranica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roudbary, Seyed Ali</au><au>Saadat, Farshid</au><au>Forghanparast, Kambiz</au><au>Sohrabnejad, Reza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke</atitle><jtitle>Acta medica Iranica</jtitle><addtitle>Acta Med Iran</addtitle><date>2011</date><risdate>2011</risdate><volume>49</volume><issue>3</issue><spage>149</spage><epage>152</epage><pages>149-152</pages><issn>0044-6025</issn><eissn>1735-9694</eissn><abstract>Cerebrovascular accidents rank first in the frequency and importance among all neurological disease. Although a number of studies had shown increased level of the high sensitive C-reactive protein (hs-CRP) in patients with ischemic stroke, the association of increased hs-CRP with various type of stroke especially the assessment hs-CRP level in ischemic and hemorrhagic stroke have not been investigated. In the present study, we assessed the concentration of hs-CRP in patients with documented ischemic and hemorrhagic stroke in the first 24 hours of the onset of symptoms. Thirty-two patients with Ischemic and hemorrhagic stroke were evaluated at neurology department of Poursina Hospital. The presence of baseline vascular risk factors, including hypertension, diabetes mellitus, hypercholesterolemia, obesity, and smoking, was determined. The blood samples were then collected and routine hematology and biochemistry tests were done. hs-CRP levels were determined using a highly sensitive immunonephelometric method. In this cross sectional study, the age of patient varied from 45-85 years (Mean 70.9 ± 9.4). Serum level of hs-CRP in Ischemic patients were 18.92 ± 11.28 and in hemorrhagic group was 2.65 ± 1.7. This relationship was statistically significant (P&lt;0.0001). It might be concluded that hs-CRP might be considered as a usefully adjunct method for the initial diagnosis of the type of stroke.</abstract><cop>Iran</cop><pub>Tehran University of Medical Sciences</pub><pmid>21681701</pmid><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0044-6025
ispartof Acta medica Iranica, 2011, Vol.49 (3), p.149-152
issn 0044-6025
1735-9694
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_449ab9181e9642bab5e037f49c25c941
source Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Aged
Aged, 80 and over
Biomarkers - blood
Brain Ischemia - blood
Brain Ischemia - complications
Brain Ischemia - diagnosis
C-Reactive Protein - analysis
Cerebrovascuar Accidents
Diagnosis, Differential
Female
Hemorrhagic Stroke
High Sensitive C-reactive Protein (hs-CRP)
Humans
Intracranial Hemorrhages - blood
Intracranial Hemorrhages - complications
Intracranial Hemorrhages - diagnosis
Ischemic Stroke
Male
Middle Aged
Stroke - etiology
title Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20C-reactive%20protein%20level%20as%20a%20biomarker%20for%20differentiation%20of%20ischemic%20from%20hemorrhagic%20stroke&rft.jtitle=Acta%20medica%20Iranica&rft.au=Roudbary,%20Seyed%20Ali&rft.date=2011&rft.volume=49&rft.issue=3&rft.spage=149&rft.epage=152&rft.pages=149-152&rft.issn=0044-6025&rft.eissn=1735-9694&rft_id=info:doi/&rft_dat=%3Cproquest_doaj_%3E872436667%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d218t-d0ebecf2e8f855d29e3a3a01a16971a2935b0e73a87bee4c5eb7dc5af83c048b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=873854289&rft_id=info:pmid/21681701&rfr_iscdi=true